Xenon Pharmaceuticals, Inc. (XENE)
52.79
+1.58
(+3.09%)
USD |
NASDAQ |
Jun 09, 16:00
52.79
0.00 (0.00%)
After-Hours: 20:00
Xenon Pharmaceuticals SG&A Expense (Quarterly) : 23.82M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Praxis Precision Medicines, Inc. | 27.87M |
| Psyence Biomedical Ltd. | 0.2659M |
| AbbVie, Inc. | 3.578B |
| Aurinia Pharmaceuticals, Inc. | 22.03M |
| enGene Therapeutics, Inc. | 8.93M |